Revenue - Gujarat Themis Biosyn Ltd (BSE:506879) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 408.7 INR 0.99%

Updated:

Gujarat Themis Biosyn Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Gujarat Themis Biosyn Ltd
Revenue Peer Comparison

DRREDDY

CIPLA

SUNPHARMA

ZYDUSLIFE

M

MANKIND

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Gujarat Themis Biosyn Ltd BSE:506879	Revenue ₹1.6B	CAGR 3-Years 19%	CAGR 5-Years 31%	CAGR 10-Years 18%
	Dr Reddy's Laboratories Ltd NSE:DRREDDY	Revenue ₹272.1B	CAGR 3-Years 13%	CAGR 5-Years 13%	CAGR 10-Years N/A
	Cipla Ltd NSE:CIPLA	Revenue ₹253.5B	CAGR 3-Years 10%	CAGR 5-Years 10%	CAGR 10-Years 10%
	Sun Pharmaceutical Industries Ltd NSE:SUNPHARMA	Revenue ₹474.4B	CAGR 3-Years 13%	CAGR 5-Years 10%	CAGR 10-Years 12%
	Zydus Lifesciences Ltd NSE:ZYDUSLIFE	Revenue ₹186.8B	CAGR 3-Years 9%	CAGR 5-Years 8%	CAGR 10-Years 11%
M	Mankind Pharma Ltd NSE:MANKIND	Revenue ₹87.5B	CAGR 3-Years 14%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Gujarat Themis Biosyn Ltd's Revenue amounts to 1.6B INR.

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Gujarat Themis Biosyn Ltd have been 19% over the past three years , 31% over the past five years , and 18% over the past ten years .

Join more than 132,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.